Tolcapone News

Tolcapone currently has 3 news articles, with 20 predicted indications.

This page combines the AI-predicted indications for Tolcapone with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

Original indication: Tasmar is indicated in combination with levodopa / benserazide or levodopa / carbidopa for use in patients with levodopa-responsive idiopathic Parkinson’s disease and motor fluctuations, who failed...
Evidence level: L5
Predicted indications (20):
- juvenile onset Parkinson disease 19A (100.0%)
- hereditary late onset Parkinson disease (100.0%)
- atypical juvenile parkinsonism (100.0%)
- X-linked parkinsonism-spasticity syndrome (99.9%)
- Rasmussen subacute encephalitis (99.9%)
- parkinsonian-pyramidal syndrome (99.9%)
- myelitis (99.9%)
- PLA2G6-associated neurodegeneration (99.9%)
- transaldolase deficiency (99.8%)
- hemiparkinsonism-hemiatrophy syndrome (99.8%)
- fructose-1,6-bisphosphatase deficiency (99.8%)
- early-onset parkinsonism-intellectual disability syndrome (99.7%)
- Lewy body dementia (99.6%)
- Parkinson disease (99.6%)
- X-linked intellectual disability-ataxia-apraxia syndrome (99.6%)
- polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis (99.6%)
- X-linked intellectual disability-cerebellar hypoplasia syndrome (99.5%)
- paralysis agitans, juvenile, of Hunt (99.5%)
- atypical glycine encephalopathy (99.5%)
- CLCN4-related X-linked intellectual disability syndrome (99.5%)